cutera_8k-080309.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 

 
FORM 8-K
 

 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
August 3, 2009
Date of Report (date of earliest event reported)
 
Logo
 


 Cutera, Inc.
(Exact name of Registrant as specified in its charter)
 

 
         
Delaware
 
000-50644
 
77-0492262
(State or other jurisdiction of
incorporation or organization)
 
(Commission File Number)
 
(I.R.S. Employer
Identification Number)
 
3240 Bayshore Blvd.
Brisbane, California 94005
(Address of principal executive offices)
 
(415) 657-5500
(Registrant’s telephone number, including area code)
 
N/A
(Former name or former address, if changed since last report)
 

 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

 
Item 2.02.
Results of Operations and Financial Condition.
 
On August 3, 2009, we are issuing a press release and holding a conference call regarding our financial results for the second quarter ended June 30, 2009. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.
 
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
 
Item 9.01.
Financial Statements and Exhibits.
 
(d)
Exhibits.
 
     
 
Exhibit No.
 
  
Description
   
99.1
  
Press Release of Cutera, Inc. dated as of August 3, 2009.


 
 

 


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


 
     
Date: August 3, 2009
 
/S/ RONALD J. SANTILLI
   
Ronald J. Santilli
   
Executive Vice President and Chief Financial Officer
   
(Principal Financial and Accounting Officer)
 
 
 
 
 
 
 

cutera_8k-ex9901.htm
EXHIBIT 99.1
Logo

 
FOR IMMEDIATE RELEASE

CONTACTS:

Cutera, Inc.
Ron Santilli
Chief Financial Officer
415-657-5500

Investor Relations
John Mills
Integrated Corporate Relations, Inc.
310-954-1100
john.mills@icrinc.com

Cutera Reports Second Quarter 2009 Results

BRISBANE, Calif., August 3, 2009 -- Cutera, Inc. (NASDAQ: CUTR), a leading provider of laser and other light-based aesthetic systems for practitioners worldwide, today reported financial results for the second quarter ended June 30, 2009.

Second quarter 2009 revenue was $11.7 million, compared to $24.8 million in the same period last year.  Net loss for the second quarter of 2009 was $2.4 million, or $0.18 per diluted share, compared to net profit of $0.7 million, or $0.05 per diluted share, in the second quarter of 2008.  Our cash flow from operations was break-even in the second quarter as our net loss was offset primarily by reductions in our accounts receivable and inventory balances.

Kevin Connors, President and CEO of Cutera, stated, “Our prospects continue to experience demand for our products from the end user; however, many of these prospects are currently reluctant to make major capital equipment purchases during these unstable economic times.   To better capitalize on the opportunities we are seeing in this challenging market and to better position our sales force for long-term positive results, we recently promoted Chris West to Vice President of North American Sales.”

“During the second quarter of 2009, we recorded certain operating expenses associated with restructuring charges, bad debt expense, and higher than normal non-cash stock-based compensation charges, that are not expected to recur in the second half of 2009.  As our restructuring efforts improve our operating efficiencies, we expect our quarterly operating expenses to decline in the second half  of 2009, compared to the second quarter of 2009, and assuming revenue of approximately $15.0 million, we believe we will become profitable.”

“In the current market environment, we believe that the core market of dermatologists, plastic surgeons and other established medical offices provides us with the best opportunities in our industry. Therefore, we are actively focusing our sales, marketing and new product development efforts on this segment of our market.”

 
-1-

 

Mr. Connors concluded, “While the near-term prospects for our industry are difficult to predict due to the current economic uncertainty, we believe that our worldwide distribution network, strong balance sheet with $104.9 million in cash and investments – with no debt, a broad portfolio of products, and various research and development projects underway, offer continuing, long-term opportunities for our company.”
 
Conference Call:
 
The conference call to discuss these results is scheduled to begin at 2:00 p.m. PT (5:00 p.m. ET) on August 3, 2009. The call will be broadcast live over the Internet hosted at the Investor Relations section of Cutera's website at www.cutera.com, and will be archived online within one hour of its completion and continue through 8:59 p.m. PT (11:59 p.m. ET) on August 17, 2009. In addition, you may call (866) 225-8754 to listen to the live broadcast. Participating in the call will be Kevin Connors, President and Chief Executive Officer, and Ron Santilli, Chief Financial Officer.
 
About Cutera, Inc.
 
Brisbane, California-based Cutera is a leading provider of laser and other light-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
 
 
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning Cutera's ability to grow its business, increase revenue, manage costs and expenses, generate additional cash, regain profitability, develop and commercialize existing and new products and applications, improve the performance of its worldwide sales and distribution network, and statements regarding long-term prospects are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein.  Potential risks and uncertainties that could affect Cutera's business and cause its financial results to differ materially from those contained in the forward-looking statements include the global economic crisis, which may reduce consumer demand for its products, cause potential customers to delay their purchase decisions and make it more difficult for some potential customers to obtain credit financing; its ability to increase revenue, manage costs and expenses and improve sales productivity and  performance worldwide; its ability to successfully develop and acquire new products and applications and market them to both its installed base and new customers; the length of the sales cycle process; unforeseen events and circumstances relating to its operations; government regulatory actions; and those other factors described in the section entitled, “Risk Factors,” in its most recent Form 10-Q as filed with the Securities and Exchange Commission on August 3, 2009. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events. Cutera's second quarter ended June 30, 2009 financial performance, as discussed in this release, is preliminary and unaudited, and subject to adjustment.

 
-2-

 
 
CUTERA, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)

 
   
June 30,
   
December 31,
 
   
2009
   
2008
 
             
Assets
           
Current assets:
           
Cash and cash equivalents
  $ 35,445     $ 36,540  
Marketable investments
    61,857       60,653  
Accounts receivable, net
    2,828       5,792  
Inventories
    8,702       9,927  
Deferred tax asset
    4,652       4,257  
Other current assets and prepaid expenses
    4,548       1,771  
Total current assets
    118,032       118,940  
                 
Property and equipment, net
    1,101       1,357  
Long-term investments
    7,640       9,627  
Intangibles, net
    926       1,025  
Deferred tax asset, net of current portion
    6,165       6,527  
Total assets
  $ 133,864     $ 137,476  
                 
Liabilities and Stockholders' Equity
               
Current liabilities:
               
Accounts payable
  $ 1,127     $ 1,690  
Accrued liabilities
    7,737       8,848  
Deferred revenue
    6,506       6,758  
Total current liabilities
    15,370       17,296  
                 
Deferred rent
    1,603       1,713  
Deferred revenue, net of current portion
    3,134       4,907  
Income tax liability
    1,367       1,452  
Total liabilities
    21,474       25,368  
                 
Stockholders’ equity:
               
Common stock
    13       13  
Additional paid-in capital
    82,985       80,318  
Retained earnings
    30,741       31,410  
Accumulated other comprehensive income (loss)
    (1,349 )     367  
Total stockholders’ equity
    112,390       112,108  
   Total liabilities and stockholders’ equity
  $ 133,864     $ 137,476  

 
-3-

 

 
CUTERA, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)

 
   
Three Months Ended
   
Six Months Ended
 
   
June 30,
   
June 30,
 
   
2009
   
2008
   
2009
   
2008
 
                         
Net revenue
  $ 11,665     $ 24,754     $ 26,095     $ 46,372  
Cost of revenue
    5,130       9,271       11,066       17,490  
Gross profit
    6,535       15,483       15,029       28,882  
                                 
Operating expenses:
                               
Sales and marketing
    6,071       10,361       13,074       20,710  
Research and development
    1,495       2,004       3,238       3,789  
General and administrative
    3,616       3,023       6,136       5,964  
Litigation settlement
    -       -       850       -  
Total operating expenses
    11,182       15,388       23,298       30,463  
Income (loss) from operations
    (4,647 )     95       (8,269 )     (1,581 )
Interest and other income, net
    511       857       1,110       1,758  
Income (loss) before income taxes
    (4,136 )     952       (7,159 )     177  
Provision (benefit) for income taxes
    (1,772 )     291       (2,967 )     58  
Net income (loss)
  $ (2,364 )   $ 661     $ (4,192 )   $ 119  
                                 
Net income (loss) per share:
                               
Basic
  $ (0.18 )   $ 0.05     $ (0.32 )   $ 0.01  
Diluted
  $ (0.18 )   $ 0.05     $ (0.32 )   $ 0.01  
                                 
Weighted-average number of shares used in per share calculations:
                               
Basic
    13,317       12,764       13,219       12,753  
Diluted
    13,317       13,465       13,219       13,457  


 
-4-

 

CUTERA, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)


   
Three Months Ended
   
Six Months Ended
 
   
June 30,
   
June 30,
 
   
2009
   
2008
   
2009
   
2008
 
Cash flows from operating activities:
                       
Net income (loss)
  $ (2,364 )   $ 661     $ (4,192 )   $ 119  
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
                               
Stock-based compensation
    1,456       1,327       2,501       2,657  
Tax deficit from stock-based compensation
    (87 )     (51 )     (113 )     (51 )
Depreciation and amortization
    225       228       453       451  
Change in deferred tax asset
    139       (13 )     34       (28 )
Change in allowance for doubtful accounts
    498       13       553       89  
Provision for excess and obsolete inventories
    130       17       503       17  
Other
    32       -       -       -  
Changes in assets and liabilities:
                               
Accounts receivable
    1,936       (897 )     2,411       1,446  
Inventories
    1,014       758       722       (1,093 )
Other current assets and prepaid expenses
    (1,085 )     288       (1,967 )     48  
Accounts payable
    (408 )     (504 )     (563 )     (436 )
Accrued liabilities
    (429 )     1,160       (1,111 )     (1,923 )
Deferred rent
    (55 )     3       (110 )     37  
Deferred revenue
    (957 )     482       (2,025 )     1,270  
Income tax liability
    (54 )     39       (85 )     398  
Net cash provided by (used in) operating activities
    (9 )     3,511       (2,989 )     3,001  
                                 
Cash flows from investing activities:
                               
Acquisition of property and equipment
    (36 )     (35 )     (98 )     (221 )
Proceeds from sales of marketable investments
    9,774       3,835       16,352       41,195  
Proceeds from maturities of marketable investments
    1,100       7,108       2,245       9,670  
Purchase of marketable investments
    (11,342 )     (32,290 )     (16,884 )     (44,495 )
Net cash provided by (used in) investing activities
    (504 )     (21,382 )     1,615       6,149  
                                 
Cash flows from financing activities:
                               
Proceeds from exercise of stock options and employee stock purchase plan
    165       225       279       260  
Net cash provided by financing activities
    165       225       279       260  
                                 
Net increase (decrease) in cash and cash equivalents
    (348 )     (17,646 )     (1,095 )     9,410  
Cash and cash equivalents at beginning of period
    35,793       38,110       36,540       11,054  
Cash and cash equivalents at end of period
  $ 35,445     $ 20,464     $ 35,445     $ 20,464  
 

 
 
-5-

 


 
CONSOLIDATED REVENUE HIGHLIGHTS
 
(in thousands, except percentage data)
 
(unaudited)
 
                                     
   
Three Months Ended June 30,
   
Six Months Ended June 30,
 
   
2009
   
2008
   
Change
   
2009
   
2008
   
Change
 
                                     
Revenue By Geography:
                                   
United States
  $ 4,551     $ 12,383       -63%     $ 10,896     $ 24,768       -56%  
International
    7,114       12,371       -42%       15,199       21,604       -30%  
    $ 11,665     $ 24,754       -53%     $ 26,095     $ 46,372       -44%  
                                                 
Revenue By Product Category:
                                               
Products
  $ 5,664     $ 18,364       -69%     $ 13,702     $ 33,690       -59%  
Product upgrades
    1,201       2,154       -44%       2,955       4,385       -33%  
Service
    3,397       2,686       +26%       6,650       5,391       +23%  
Titan refills
    1,403       1,550       -9%       2,788       2,906       -4%  
    $ 11,665     $ 24,754       -53%     $ 26,095     $ 46,372       -44%  

 
 
 
 
 -6-